Shivani Garg, MD, from The University of Wisconsin School of Medicine and Public Health, answers our questions about her research on improving pneumococcal vaccination rates among patients with systemic...
In a systematic review, Richard Brindle, MD, and colleagues investigated whether certain antibiotics, routes of administration, and/or treatment duration affected treatment outcomes among patients with...
In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.
In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.
In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Psych Congress cochair Charles Raison, MD, wants mental health clinicians to be aware of the limits of standard antidepressants as well as the transformational changes emerging in the treatment of...
